» Articles » PMID: 28337437

Bioengineering Approaches to Mature Human Pluripotent Stem Cell-Derived Cardiomyocytes

Overview
Specialty Cell Biology
Date 2017 Mar 25
PMID 28337437
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Human pluripotent stem cell-derived cardiomyocytes (hPSC-CM) represent a potential unlimited cell supply for cardiac tissue engineering and possibly regenerative medicine applications. However, hPSC-CMs produced by current protocols are not representative of native adult human cardiomyocytes as they display immature gene expression profile, structure and function. In order to improve hPSC-CM maturity and function, various approaches have been developed, including genetic manipulations to induce gene expression, delivery of biochemical factors, such as triiodothyronine and alpha-adrenergic agonist phenylephrine, induction of cell alignment in 3D tissues, mechanical stress as a mimic of cardiac load and electrical stimulation/pacing or a combination of these. In this mini review, we discuss biomimetic strategies for the maturation for hPSC-CMs with a particular focus on electromechanical conditioning methods.

Citing Articles

Recent advancements of human iPSC derived cardiomyocytes in drug screening and tissue regeneration.

Huang Y, Wang T, Lopez M, Hirano M, Hasan A, Shin S Microphysiol Syst. 2024; 4:2.

PMID: 39430371 PMC: 11488690. DOI: 10.21037/mps-20-3.


Harnessing stem cell and lineage reprogramming technology to treat cardiac fibrosis.

Zeng N, Tang W, Wu Y, Fan H, Xie S, Cao N Cell Regen. 2023; 12(1):39.

PMID: 38072904 PMC: 10710977. DOI: 10.1186/s13619-023-00182-7.


Comparative Analysis of Heart Regeneration: Searching for the Key to Heal the Heart-Part II: Molecular Mechanisms of Cardiac Regeneration.

Castillo-Casas J, Cano-Carrillo S, Sanchez-Fernandez C, Franco D, Lozano-Velasco E J Cardiovasc Dev Dis. 2023; 10(9).

PMID: 37754786 PMC: 10531542. DOI: 10.3390/jcdd10090357.


Integrated Manufacturing of Suspended and Aligned Nanofibrous Scaffold for Structural Maturation and Synchronous Contraction of HiPSC-Derived Cardiomyocytes.

Liu L, Xu F, Jin H, Qiu B, Yang J, Zhang W Bioengineering (Basel). 2023; 10(6).

PMID: 37370633 PMC: 10295015. DOI: 10.3390/bioengineering10060702.


Differentiating Human Pluripotent Stem Cells to Cardiomyocytes Using Purified Extracellular Matrix Proteins.

Barnes A, Holmstoen T, Bonham A, Rowland T Bioengineering (Basel). 2022; 9(12).

PMID: 36550926 PMC: 9774171. DOI: 10.3390/bioengineering9120720.


References
1.
Schaaf S, Shibamiya A, Mewe M, Eder A, Stohr A, Hirt M . Human engineered heart tissue as a versatile tool in basic research and preclinical toxicology. PLoS One. 2011; 6(10):e26397. PMC: 3197640. DOI: 10.1371/journal.pone.0026397. View

2.
Gherghiceanu M, Barad L, Novak A, Reiter I, Itskovitz-Eldor J, Binah O . Cardiomyocytes derived from human embryonic and induced pluripotent stem cells: comparative ultrastructure. J Cell Mol Med. 2011; 15(11):2539-51. PMC: 3822963. DOI: 10.1111/j.1582-4934.2011.01417.x. View

3.
Robertson C, Tran D, George S . Concise review: maturation phases of human pluripotent stem cell-derived cardiomyocytes. Stem Cells. 2013; 31(5):829-37. PMC: 3749929. DOI: 10.1002/stem.1331. View

4.
Otsuji T, Minami I, Kurose Y, Yamauchi K, Tada M, Nakatsuji N . Progressive maturation in contracting cardiomyocytes derived from human embryonic stem cells: Qualitative effects on electrophysiological responses to drugs. Stem Cell Res. 2010; 4(3):201-13. DOI: 10.1016/j.scr.2010.01.002. View

5.
Rao C, Prodromakis T, Kolker L, Chaudhry U, Trantidou T, Sridhar A . The effect of microgrooved culture substrates on calcium cycling of cardiac myocytes derived from human induced pluripotent stem cells. Biomaterials. 2012; 34(10):2399-411. PMC: 3605579. DOI: 10.1016/j.biomaterials.2012.11.055. View